Nasdaq · Common Stock · Surgical & Medical Instruments & Apparatus
18 entities across 17 jurisdictions. Read directly from the company’s own 10-K EX-21 filed 2026-08-27 — see the exhibit.
Which other public companies file entities in the same places:
| Entity | Jurisdiction | Note |
|---|---|---|
| Accuray International SARL | Switzerland | |
| Accuray Europe SAS | France | |
| Accuray UK, Ltd. | United Kingdom | |
| Accuray Asia Ltd. | Hong Kong | |
| Accuray Japan K.K. | Japan | |
| Accuray Korea Limited Company | Korea | |
| Accuray Spain, S.L.U. | Spain | |
| Accuray Medical Equipment (India) Private Limited | India | |
| Accuray Medical Equipment (Rus) LLC. | Russia | |
| Accuray Medical Equipment GmbH | Germany | |
| Accuray Medical Equipment (Canada) Ltd. | Canada | |
| Accuray Mexico, S.A. de C.V. | Mexico | |
| Accuray Medical Equipment (Shanghai) Co., Ltd. | China | |
| Accuray Brasil Comércio, Importação e Exportação de Equipamentos Médicos Ltda | Brazil | |
| Accuray Belgium BV | Belgium | |
| Accuray Italy S.R.L | Italy | |
| Accuray Accelerator Technology (Chengdu) Company Limited | China | |
| Accuray LLC | Delaware |
Two standard screens, computed from the XBRL in FY2026 against FY2025. Every test shows the numbers behind it — a score with its inputs hidden is a number you cannot check.
| Year | Revenue | Net income | Free cash flow | Gross margin | Shares |
|---|---|---|---|---|---|
| FY2021 | $396.3M | −$6.3M | $36.2M | 40.3% | 92,031,000 |
| FY2022 | $429.9M | −$5.3M | −$7.1M | 37.2% | 92,095,000 |
| FY2023 | $447.6M | −$9.3M | $2.9M | 34.4% | 94,884,000 |
| FY2024 | $446.6M | −$15.5M | −$15.5M | 32.0% | 98,272,000 |
| FY2025 | $458.5M | −$1.6M | −$1.4M | 32.1% | 102,768,000 |
| FY2026 | $401.9M | −$49.2M | −$12.8M | 27.7% | — |
11 institutions tracked — 4 added, 6 reduced, 1 opened a new position, 1 sold out. Active managers added 2,169,341 shares while index money cut 7,915,473.
| Manager | Kind | Shares | Change | Value |
|---|---|---|---|---|
| BlackRock, Inc. | Index | 3,266,185 | −5,192,224 | $842.0M |
| AQR CAPITAL MANAGEMENT LLC | Hedge fund | 2,719,032 | +2,101,555 | $701.0M |
| STATE STREET CORP | Index | 485,866 | −1,531,787 | $125.3M |
| GEODE CAPITAL MANAGEMENT, LLC | Index | 1,189,377 | −1,191,462 | $306.7M |
| JPMORGAN CHASE & CO | Active fund | 376,695 | +296,852 | $97.8M |
| RENAISSANCE TECHNOLOGIES LLC | Hedge fund | 2,065,284 | −225,700 | $532.4M |
| FMR LLC | Active fund | 1,375,746 | +86,958 | $354.7M |
| BANK OF AMERICA CORP /DE/ | Active fund | 110,614 | −61,495 | $28.4M |
| MORGAN STANLEY | Active fund | 257,033 | −31,780 | $66.3M |
| CITADEL ADVISORS LLC | Hedge fund | 31,551 | +2,951 | $8.1M |
Point72 Asset Management, L.P. holds a position with no prior filing to compare against, so its change is unknown rather than zero — and it is left out of the totals above.
From 13F filings, which cover institutions managing over $100m and are filed up to 45 days after the quarter ends — so this is a considered position, not a live one, and it is not the whole shareholder register.
Ownership percentages are a vendor aggregate, not a filing — unlike everything else on this page.
ACCURAY INC files under SIC 3841 — all 38 surgical & medical instruments & apparatus companies compared on assets and F-score.
The structure map above is the Corporate Blueprint, and in the desktop it is interactive — click any entity to re-centre the map on it and walk the ownership chain. It sits alongside the screener, the scorecard and the filings lab on one desk, on your machine.
Sourced from SEC EDGAR primary filings. Figures are as reported by the company and are not investment advice. Scores are standard published screens computed from those filings; every input is shown above so you can check the arithmetic.